Court Finds Multiple Flaws in EPA’s Glyphosate Cancer Risk Assessment - Global Research
Global ResearchNov 25, 2022
The Facts
On Tues., SCOTUS upheld a $25M settlement between manufacturing company Bayer and Edwin Hardeman, a Calif. man who said he developed cancer from using the company's Roundup weed killer.
Bayer appealed the settlement citing the Environmental Protection Agency's (EPA) official stance that glyphosate -the chemical said to cause non-Hodgkin's lymphoma- is not carcinogenic.
The Spin
Establishment-critical narrative
While it was a long and hard-fought journey, Mr. Hardeman's perseverance has finally held Monsanto and Bayer accountable for corporate malfeasance and opened up the opportunity for thousands of other cancer patients to obtain justice for themselves and their families. Corporations are being held accountable.
Pro-establishment narrative
The EPA has ruled Roundup a safe product and Bayer has won four consecutive cases in state courts. These costly settlements against companies who do their due diligence are risking the future of innovation in agriculture, health, and other industries.
